MHRA updates warfarin safety advice

Safety issues surrounding the use of warfarin have been reviewed by the MHRA.

As detailed in the agency's Public Assessment Report, the drug's contraindications have been tightened to include use within 72 hours of surgery or 48 hours of labour.

Active peptic ulcer, risk factors for haemorrhage and thyroid disorders are listed amongst the circumstances in which use of warfarin requires caution.

The list of potential drug interactions has been updated and liver dysfunction has been added as a potential adverse effect.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases